Galapagos, Gilead Announce Global Partnership to Develop Filgotinib to Treat Rheumatoid Arthritis, Other Inflammatory Diseases
December 17, 2015 at 04:14 AM EST
Galapagos NV (NASDAQ: GLPG) and Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the companies have entered into a global ...
